Radiopharm Theranostics Balance Sheet Health
Financial Health criteria checks 3/6
Radiopharm Theranostics has a total shareholder equity of A$27.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$72.0M and A$44.7M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$18.58m |
| Equity | AU$27.35m |
| Total liabilities | AU$44.68m |
| Total assets | AU$72.04m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RAD's short term assets (A$22.8M) exceed its short term liabilities (A$17.6M).
Long Term Liabilities: RAD's short term assets (A$22.8M) do not cover its long term liabilities (A$27.1M).
Debt to Equity History and Analysis
Debt Level: RAD is debt free.
Reducing Debt: RAD had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RAD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RAD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.4% each year